Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.480
-0.080 (-5.13%)
At close: Feb 27, 2026, 4:00 PM EST
1.490
+0.010 (0.68%)
After-hours: Feb 27, 2026, 6:53 PM EST
Fate Therapeutics Market Cap
Fate Therapeutics has a market cap or net worth of $170.72 million as of February 27, 2026. Its market cap has increased by 19.89% in one year.
Market Cap
170.72M
Enterprise Value
44.91M
1-Year Change
19.89%
Ranking
Category
Stock Price
$1.48
Market Cap Chart
Since October 1, 2013, Fate Therapeutics's market cap has increased from $126.10M to $170.72M, an increase of 35.39%. That is a compound annual growth rate of 2.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 172.10M | 51.76% |
| Dec 31, 2025 | 113.40M | -39.65% |
| Dec 31, 2024 | 187.90M | -49.05% |
| Dec 29, 2023 | 368.80M | -62.38% |
| Dec 30, 2022 | 980.40M | -82.45% |
| Dec 31, 2021 | 5.59B | -29.57% |
| Dec 31, 2020 | 7.93B | 436.27% |
| Dec 31, 2019 | 1.48B | 78.70% |
| Dec 31, 2018 | 827.80M | 225.01% |
| Dec 29, 2017 | 254.70M | 197.20% |
| Dec 30, 2016 | 85.70M | -11.47% |
| Dec 31, 2015 | 96.80M | -6.47% |
| Dec 31, 2014 | 103.50M | -19.01% |
| Dec 31, 2013 | 127.80M | 1.35% |
| Oct 1, 2013 | 126.10M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tonix Pharmaceuticals Holding | 178.73M |
| Caribou Biosciences | 177.59M |
| Milestone Pharmaceuticals | 173.71M |
| Karyopharm Therapeutics | 172.62M |
| Compugen | 169.30M |
| ProQR Therapeutics | 167.50M |
| Rani Therapeutics Holdings | 166.48M |
| Whitehawk Therapeutics | 165.42M |